Diagnosis of choroid plexus papilloma: Current perspectives and future directions
作者机构:Department of Medical VirologySchool of MedicineAhvaz Jundishapur University of Medical SciencesAhvaz ***Iran Department of Laboratory SciencesSchool of Allied Medical SciencesAhvaz Jundishapur University of Medical SciencesAhvaz ***Iran Department of PhysiologySchool of MedicineAhvaz Jundishapur University of Medical SciencesAhvaz ***Iran Department of NeurologySchool of MedicineAhvaz Jundishapur University of Medical SciencesAhvaz ***Iran
出 版 物:《Cancer Pathogenesis and Therapy》 (癌症发生与治疗(英文))
年 卷 期:2024年第2卷第3期
页 面:173-179页
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题:Cerebral ventricle neoplasms Biomarkers Neuroimaging Translational research Histopathological features
摘 要:Choroid plexus papilloma(CPP)is a rare,slow-growing,and typically benign brain tumor that predominantly affects *** is characterized by well-defined circular or lobulated masses in the ventricles,leading to symptoms related to increased intracranial pressure and *** diagnosis relies on a combination of clinical presentation,imaging findings,and histological *** World Health Organization(WHO)classification categorizes choroid plexus tumors into CPP(GradeІ),atypical CPP(aCPP,Grade Ⅱ),and choroid plexus carcinoma(CPC,Grade Ⅲ).This article reviewed current diagnostics modalities and explored the emergence of new diagnostic methods for *** on molecular markers and genetic alterations associated with CPP is ongoing,and some potential markers have been *** results offered insights into potential therapeutic targets and personalized treatment approaches for *** in radiomics and liquid biopsy hold promise for improving diagnostic accuracy and monitoring treatment outcomes for choroid plexus *** can provide quantitative data from imaging studies,whereas liquid biopsy can analyze tumor-derived genetic material and molecular markers from body fluids,such as cerebrospinal fluid(CSF)and *** rapidly evolving fields of molecular and genetic research and novel diagnostic methods require continuous updates and advancements before their application in clinical *** hope that these advancements will lead to earlier and more precise diagnoses,better treatment options,and improved outcomes in patients with CPP and other brain tumors.